PGEN Randal J Kirk sells $3.8M worth of shares
Nov 22, 2025, 5:34 AM
0.00%
What does PGEN do
Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
Randal J Kirk sold 942,832 shares of PGEN on 20 November at $4.08 per share, worth a total of $3.8M. They now own 6,491,552 PGEN shares, or a 13% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.